TY - JOUR
T1 - Determination of inhibitory potency of argatroban toward thrombin by electrophoretically mediated microanalysis
AU - Pochet, L.
AU - Bouckaert, C.
AU - Servais, A.-C.
AU - Farcas, E.
AU - Bettonville, V.
AU - Fillet, M.
PY - 2013/1/1
Y1 - 2013/1/1
N2 - Developing an EMMA method for enzymatic assay remains a challenge, particularly using UV detection. Indeed, it is necessary to optimize the separation conditions while allowing the enzymatic reaction to occur within the capillary respecting kinetic constraints and achieving enough sensitivity. In this work, such EMMA methodology was set up to evaluate the inhibitory potency of drugs toward thrombin, a serine protease implicated in the coagulation cascade. To achieve our goal, the separation buffer, the injection sequence, the internal standard and the chromogenic substrate were investigated. The newly developed system was then assessed determining the kinetic K constant for the selected substrate and compared with the results obtained with a continuous spectrophotometer cell assay. Secondly, the K inhibitory constant of the thrombin inhibitor argatroban was determined and found in agreement with the published value.
AB - Developing an EMMA method for enzymatic assay remains a challenge, particularly using UV detection. Indeed, it is necessary to optimize the separation conditions while allowing the enzymatic reaction to occur within the capillary respecting kinetic constraints and achieving enough sensitivity. In this work, such EMMA methodology was set up to evaluate the inhibitory potency of drugs toward thrombin, a serine protease implicated in the coagulation cascade. To achieve our goal, the separation buffer, the injection sequence, the internal standard and the chromogenic substrate were investigated. The newly developed system was then assessed determining the kinetic K constant for the selected substrate and compared with the results obtained with a continuous spectrophotometer cell assay. Secondly, the K inhibitory constant of the thrombin inhibitor argatroban was determined and found in agreement with the published value.
UR - http://www.scopus.com/inward/record.url?scp=84882981909&partnerID=8YFLogxK
U2 - 10.1016/j.talanta.2013.07.030
DO - 10.1016/j.talanta.2013.07.030
M3 - Article
AN - SCOPUS:84882981909
SN - 0039-9140
VL - 116
SP - 719
EP - 725
JO - Talanta
JF - Talanta
ER -